A revolution is happening with the treatment of obesity.
Category
🗞
NewsTranscript
00:00Recent advances in weight loss treatments have introduced a new generation of drugs that offer promising results.
00:08These include GLP analogues like lyraglutide and sermaglutide,
00:15which mimic a natural hormone to promote fullness and facilitate weight loss.
00:21Sermaglutide in particular has gained attention for its effectiveness,
00:26with clinical trials showing an average weight loss of 16% over 68 weeks.
00:32The latest addition is terzipatide, targeting both the GLP-1 receptor and the glucagon receptor,
00:40leading to an average weight loss of 20.9% at higher doses after 72 weeks.
00:48These drugs represent a significant leap forward in obesity treatments,
00:52offering hope that being overweight could indeed become a thing of the past.
00:57The question is, however, whether the British public is ready to try these new treatments.